For ER-negative breast cancer cells, evidence shows a human EGF receptor 2 (HER2)-dependent pathway causes S1PR4 to stimulate the ERK signal pathway. An additional study proved that by downregulating SphK1, the growth of HER2 breast tumors reduced as well. This evidence concerns the gene ERBB2 and breast neoplasm.